reviewTop 1% cited
Matrix metalloproteinase degradation of extracellular matrix: biological consequences
Current Opinion in Cell Biology · 1998 · Vol. 10(5) · pp. 602–608
Steven D. Shapiro✉(Barnes-Jewish Hospital)
Protease and Inhibitor MechanismsPeptidase Inhibition and AnalysisSignaling Pathways in DiseaseBiologyExtracellular matrixMatrix metalloproteinaseCell biologyMatrix (chemical analysis)MutagenesisMetalloproteinaseIn vivoExtracellularComputational biology
MeSH terms
Cardiovascular DiseasesExtracellular MatrixMetalloendopeptidasesNeoplasmsPemphigoid, BullousPulmonary EmphysemaMutagenesis, Site-Directed
Funding
- National Institutes of Health
Citations
718
FWCI
15.33
field-weighted impact
References
57
Percentile
99%
vs. same field & year
Citations per year
Cited by
Regulation of matrix metalloproteinase expression in tumor invasion
The FASEB Journal · 1999 · 1,497 citations
Fibronectin Polymerization Regulates the Composition and Stability of Extracellular Matrix Fibrils and Cell-Matrix Adhesions
Molecular Biology of the Cell · 2002 · 644 citations
Matrix metalloproteinases as modulators of inflammation and innate immunity
Nature reviews. Immunology · 2004 · 1,886 citations
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
International Journal of Cancer · 2002 · 635 citations
Matrix Metalloproteinases
Journal of Biological Chemistry · 1999 · 3,888 citations
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine · 2012 · 16,064 citations
References
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
Cell · 1997 · 4,485 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.